Toggle navigation
Home
Search
Services
Blog
Contact
About
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kmt Hepatech, Inc., Edmonton, AB, Canada
Search grants from Kmt Hepatech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Universal Health Insurance and the Adequacy and Efficiency of Health Care
Immunoregulation of Autoimmunity
Critical Research Issues in Latino Mental Health
Regulatory Mutations in the Threonine Operon
Biology and Chemistry of Connective Tissues
Recently added grants:
Effect of Microbial Metabolites on Growth of Cryptosporidium
Immune signaling molecules involved in promoting the pathogenesis of eosinophilic esophagitis (EoE)
Evaluation of a High-Affinity and BTLA-specific HVEM Protein Agonist in vivo
Critical Lipid Species in the Hepatovirus Lifecycle
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201000016I-0-27200001-1
Application #
8539576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$1,292,503
Indirect Cost
Institution
Name
Kmt Hepatech, Inc.
Department
Type
DUNS #
202499542
City
Edmonton
State
AB
Country
Canada
Zip Code
76 2-E1
Related projects
NIH 2012
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
/ Kmt Hepatech, Inc.
$1,292,503
NIH 2011
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kneteman, Norman / Kmt Hepatech, Inc.
$1,260,145
NIH 2010
N01 AI
Animal Models of Infectious Diseases
/
$50,000
Comments
Be the first to comment on this grant